Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baidaijing is a Traditional Chinese Medicine (TCM) formulation, primarily administered in capsule form, developed for the treatment of gynecological inflammatory conditions such as trichomonas vaginitis. In clinical practice, it is often categorized as a treatment for "damp-heat" syndromes according to TCM principles. The drug is frequently studied in combination with standard antimicrobial agents like metronidazole to enhance therapeutic efficacy and reduce recurrence rates of vaginal infections. Research into Baidaijing Capsules has been conducted by institutions such as the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine to provide evidence-based support for its use in treating gynecological inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baidaijing.